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H3K4Me1, H3K4Me3 and H3K27Ac as well as presence of CpG 
islands were used to identify methylated regulatory 
elements. 
 
Results: Nineteen men and 6 women, with a median age of 
69 years, were included. Ten were current smokers, 14 ex-
smokers (stopped more than 4 weeks before surgery) and 1 
non-smoker. Fourteen patients had adenocarcinoma, eleven 
patients had squamous cell carcinoma. When compared to 
distant lung tissue, gene expression of PD-L2, HGF, VEGFR2 
and VEGFR3 were downregulated in tumor tissue. PD-L1 
expression was also downregulated in tumor tissue, but only 
in active smokers. For PD-L2, HFG, VEGFR2 and VEGFR3, 
methylation data shows a clear hypermethylation pattern in 
the promoter and enhancer regions of tumor tissue, which is 
conform the results of the transcriptome sequencing. 
Qualitative results of the expression and methylation data 
are depicted in figure 1. 
 
 
Conclusion: Our results show a lower expression of PD-L1 in 
tumors of active smokers. PD-L2, VEGFR2 and VEGFR3 and 
HGF have a lower expression in tumors overall. Methylation 
data confirms these findings. The therapeutic ratio with 
targeted treatment might be narrow as a result of this higher 
expression in distant lung tissue and in the case of immune 
checkpoint inhibitors, increase the chance of pneumonitis. 
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Purpose or Objective: Recent studies have shown that 
alterations in the pattern of radiation delivery, such as 
pulsed radiotherapy (PRT), can produce significant changes 
to the tumor microenvironment. Given the positive effects of 
PRT on maintaining tumor vasculature, we hypothesized that 
PRT treatment would allow tumor microenvironments to 
remain more oxygenated and result in better overall tumor 
killing compared with SRT. We further postulated that this 
effect would be associated with decreased tumor hypoxia, 
leading to lower vascular endothelial growth factor (VEGF) 
and stromal derived factor-1 alpha (SDF-1α) production and 
subsequently lower recruitment of bone marrow derived cells 
(BMDCs) in PRT-irradiated tumors.  
 
Material and Methods: Subcutaneous Lewis lung carcinoma 
(LLC) tumors were established in C57BL/6 mice. Tumors were 
allowed to grow to 100-200mm3 before irradiation with a 160 
kVp Faxitron cabinet (HVL: 0.77 mm Cu) using a dose rate of 
0.69 Gy/min. SRT or PRT was given to 20 Gy at 2 Gy/day 
using a 5 day-on, 2 day-off schedule to mimic clinical 
delivery. Tumors were harvested 2-3 days post treatment. 
Radiation-induced changes in the tumor microenvironment 
were examined using flow cytometry and antibody-specific 
histopathology. Normal tissue effects were determined using 
non-invasive 18F-FDG PET/CT and MR imaging after naïve 
animals were given whole-lung irradiation to 40 Gy using the 
same 2 Gy/day regimens.  
 
Results: PRT was more effective than SRT at reducing tumor 
growth rate (0.24±0.02mm3/day and 0.67±0.06mm3/day 
respectively; p<0.0001). Histopathology analysis showed a 
significant reduction in the levels of Ki-67 (13±8%), hypoxia 
(8±1%), VEGF (3.5±1%) and SDF-1α (4.2±1.5%) as well as a 
concomitant decrease in CD45+ BMDC migration (7.8±2.2%) 
after PRT when compared to SRT. Higher vessel density was 
also observed in PRT irradiated tumors. No short-term 
differences were observed in normal lung tissue after PRT or 
SRT although all irradiated animals demonstrated higher 
levels of inflammation than controls. 
 
Conclusion: Using a rapidly proliferating LLC allograft model, 
we have found evidence for improved tumor killing with PRT 
relative to SRT due to vascular maintenance. PRT irradiated 
tumors exhibited slower growth rate and reduced hypoxia 
coincident with loss of supportive mechanisms utilized by 
tumors in low oxygen microenvironments, such as 
angiogenesis and recruitment of BMDCs. This study 
demonstrates the efficacy of PRT and highlights the 
importance of microenvironment responses during tumor 
radiotherapy. We conclude that PRT represents an improved 
treatment strategy that may result in better overall patient 
outcomes with little alteration in normal tissue toxicity. 
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Purpose or Objective: The objective of this population-
based study was to provide an overview on trends and 
changing patterns in the adoption of postmastectomy 
radiotherapy (PMRT) over a 25-year period, and to validate 
the effectiveness of postoperative radiotherapy. Focused 
attention was given to disparities and barriers related to the 
use of postoperative radiotherapy in nodal positive disease 
and elderly patients. 
 
Material and Methods: The study included epidemiological 
data of 16,675 patients diagnosed with invasive breast cancer 
from 1988 to 2012, within the catchment area of the Munich 
Cancer Registry. Use of PMRT, local recurrence free survival 
(LRFS), cumulative incidence (CI) of time to local recurrence, 
relative survival and conditional overall survival (cOS), were 
analysed for different time periods (1988-1997 and 1998-
2012). Factors predicting the use of postoperative 
radiotherapy were analysed using multivariate logistic 
regression. 
 
Results: Use of PMRT was associated with significant 
improvements in local control, with a 10-year LRFS of 88.9% 
with PMRT vs. 84.1% following mastectomy alone (p<0.001). 
After adjusting for age, tumour characteristics and other 
therapies, the Cox-regression analysis for LRFS identified 
PMRT as an independent predictor for improved local control 
(hazard ratio [HR]: 2.145; 95% CI: 1.787-2.574, p<0.001). 
Patients with 1-3 involved lymph nodes had a 10-year CI of 
time to local recurrence of 13.7% following mastectomy 
alone, compared to 6.5% following PMRT (p= 0.001). 
Comparable findings were obtained for the subgroup of 
patients presenting with ≥ 4 positive lymph nodes – 
presenting with 17.8% 10-year CI of time to local recurrence 
in the mastectomy only group, compared to 8.2% in the PMRT 
group (p<0.001). All effects were smaller or extinct in elderly 
